Impact of changes in CLSI and EUCAST breakpoints for susceptibility in bloodstream infections due to extended-spectrum β-lactamase-producing Escherichia coli.

Impact of changes in CLSI and EUCAST breakpoints for susceptibility in bloodstream infections due to extended-spectrum β-lactamase-producing Escherichia coli.

Item
http://www.wikidata.org/entity/Q54351100
Clinical management of infections caused by multidrug-resistant EnterobacteriaceaeChange of antibiotic susceptibility testing guidelines from CLSI to EUCAST: influence on cumulative hospital antibiogramsThe times they are a-changin': carbapenems for extended-spectrum-β-lactamase-producing bacteriaESBL Detection: Comparison of a Commercially Available Chromogenic Test for Third Generation Cephalosporine Resistance and Automated Susceptibility Testing in EnterobactericeaeDoes the piperacillin minimum inhibitory concentration for Pseudomonas aeruginosa influence clinical outcomes of children with pseudomonal bacteremia?A Multinational, Preregistered Cohort Study of β-Lactam/β-Lactamase Inhibitor Combinations for Treatment of Bloodstream Infections Due to Extended-Spectrum-β-Lactamase-Producing EnterobacteriaceaeExtended-spectrum β-lactamase- and AmpC-producing enterobacteria in healthy broiler chickens, GermanyHigh activity of Fosfomycin and Rifampin against methicillin-resistant staphylococcus aureus biofilm in vitro and in an experimental foreign-body infection model.Impact of antibiotic MIC on infection outcome in patients with susceptible Gram-negative bacteria: a systematic review and meta-analysis.Impact of a program combining pre-authorization requirement and post-prescription review of carbapenems: an interrupted time-series analysis.Improved treatment of multidrug-resistant bacterial infections: utility of clinical studies.Preventive and therapeutic strategies in critically ill patients with highly resistant bacteria.Impact of borderline minimum inhibitory concentration on the outcome of invasive infections caused by Enterobacteriaceae treated with β-lactams: a systematic review and meta-analysis.Carbapenem susceptibility breakpoints, clinical implications with the moving target.Human-associated extended-spectrum β-lactamase in the Antarctic.Frequency of Multidrug-Resistant Organisms Cultured From Urine of Children Undergoing Clean Intermittent Catheterization.Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae.
P2860

Impact of changes in CLSI and EUCAST breakpoints for susceptibility in bloodstream infections due to extended-spectrum β-lactamase-producing Escherichia coli.

Item
http://www.wikidata.org/entity/Q54351100
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Impact of changes in CLSI and ...... se-producing Escherichia coli.
@en
Impact of changes in CLSI and ...... se-producing Escherichia coli.
@nl
type
label
Impact of changes in CLSI and ...... se-producing Escherichia coli.
@en
Impact of changes in CLSI and ...... se-producing Escherichia coli.
@nl
prefLabel
Impact of changes in CLSI and ...... se-producing Escherichia coli.
@en
Impact of changes in CLSI and ...... se-producing Escherichia coli.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P356
P1433
P1476
Impact of changes in CLSI and ...... se-producing Escherichia coli.
@en
P2093
P304
P31
P356
10.1111/J.1469-0691.2011.03673.X
P433
P478
P50
P577
P5875
P698
P921